Barbara Klencke serves as Executive at Sierra Oncology, Inc., where they oversee executive responsibilities. Since joining the company, Barbara Klencke has executed 12 insider transactions totaling $322.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Sep 23, 2024 involved purchasing 5,000 shares valued at $26.4K.
Barbara Klencke currently holds 45,000 shares of Sierra Oncology, Inc. (SRRA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Barbara Klencke has been a net buyer of SRRA stock. They have purchased $322.0K and sold $0 worth of shares.
Barbara Klencke's most recent insider trade was on Sep 23, 2024, when they purchased 5,000 shares at $5.29 per share.
Get notified when new Form 4 filings are submitted
| $5.53 |
| Discretionary |
| Aug 23, 2024 | TCRX | $28.4K | Purchase | 5,000 | $5.69 | Discretionary |
| Jun 13, 2024 | XNCR | $0 | Award | 5,986 | $N/A | Discretionary |
| Dec 14, 2023 | TCRX | $25.4K | Purchase | 5,000 | $5.08 | Discretionary |
| Jul 1, 2022 | SRRA | $275.0K | Disposition | 5,000 | $55.00 | Discretionary |
| Jul 1, 2022 | SRRA | $550.0K | Disposition | 10,000 | $55.00 | Discretionary |
| Aug 18, 2020 | SRRA | $40.7K | Purchase | 3,325 | $12.25 | Discretionary |
| Aug 18, 2020 | SRRA | $72.7K | Purchase | 5,950 | $12.22 | Discretionary |
| Aug 23, 2019 | SRRA | $47.5K | Purchase | 108,000 | $0.44 | Discretionary |
| Aug 22, 2019 | SRRA | $28.8K | Purchase | 67,000 | $0.43 | Discretionary |
| Aug 22, 2019 | SRRA | $24.3K | Purchase | 54,000 | $0.45 | Discretionary |